• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测量多药耐药蛋白介导白三烯C4转运至膜囊泡的高通量检测方法。

A high-throughput assay for measurement of multidrug resistance protein-mediated transport of leukotriene C4 into membrane vesicles.

作者信息

Tabas Linda B, Dantzig Anne H

机构信息

Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285-0424, USA.

出版信息

Anal Biochem. 2002 Nov 1;310(1):61-6. doi: 10.1016/s0003-2697(02)00282-8.

DOI:10.1016/s0003-2697(02)00282-8
PMID:12413474
Abstract

This study investigated a high-throughput assay to measure multidrug resistance-associated protein (MRP1)-mediated uptake into membrane vesicles. Typically, a rapid filtration technique using a 12-filter vacuum manifold is used. We report here the development of a 96-well microtiter dish assay. MRP1-transfected HeLa cells (HeLa-T5) were used for the membrane vesicle preparations. The uptake of 50nM [3H]leukotriene C(4) (LTC(4)) was measured in a 96-well microtiter dish with rapid filtration onto a Perkin Elmer unifilter GF/B plate using a Perkin Elmer Filtermate 196. Counting of the isotype was conducted with a Perkin Elmer Top Count NXT. Uptake was adenosine 5'-triphosphate-dependent and linear over a 120-s time course. Uptake was inhibited by the leukotriene D(4) antagonist, MK 571, with a k(i) of 0.67 microM, and by the anti-MRP1 monoclonal antibody QCRL-3 but not by QCRL-1. Inhibition by estradiol-17-beta-glucuronide was 35-fold greater than inhibition by estradiol-3-beta-glucuronide. The kinetic parameters for LTC(4) uptake were determined to be a K(m) of 157nM with a V(max) of 344pmol/min/mg protein. The properties of MRP1-mediated transport of LTC(4) are consistent with those previously reported. The microtiter dish assay is a more expedient method for measuring transport into membrane vesicles and will have applications to other transporters.

摘要

本研究调查了一种高通量检测方法,用于测量多药耐药相关蛋白(MRP1)介导的膜囊泡摄取。通常,使用12孔滤膜真空歧管的快速过滤技术。我们在此报告一种96孔微量滴定板检测方法的开发。转染了MRP1的HeLa细胞(HeLa-T5)用于制备膜囊泡。在96孔微量滴定板中测量50nM [3H]白三烯C4(LTC4)的摄取,使用Perkin Elmer Filtermate 196快速过滤到Perkin Elmer unifilter GF/B板上。使用Perkin Elmer Top Count NXT进行同位素计数。摄取是依赖于腺苷5'-三磷酸的,并且在120秒的时间进程中呈线性。摄取受到白三烯D4拮抗剂MK 571的抑制,其抑制常数(Ki)为0.67 microM,也受到抗MRP1单克隆抗体QCRL-3的抑制,但不受QCRL-1的抑制。雌二醇-17-β-葡萄糖醛酸苷的抑制作用比雌二醇-3-β-葡萄糖醛酸苷的抑制作用大35倍。LTC4摄取的动力学参数确定为米氏常数(Km)为157nM,最大反应速度(Vmax)为344pmol/分钟/毫克蛋白。MRP1介导的LTC4转运特性与先前报道的一致。微量滴定板检测方法是一种更便捷的测量膜囊泡摄取的方法,并且将应用于其他转运体。

相似文献

1
A high-throughput assay for measurement of multidrug resistance protein-mediated transport of leukotriene C4 into membrane vesicles.一种用于测量多药耐药蛋白介导白三烯C4转运至膜囊泡的高通量检测方法。
Anal Biochem. 2002 Nov 1;310(1):61-6. doi: 10.1016/s0003-2697(02)00282-8.
2
Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.多药耐药蛋白(MRP)介导的白三烯C4和化疗药物在膜囊泡中的转运。谷胱甘肽依赖性长春新碱转运的证明。
J Biol Chem. 1996 Apr 19;271(16):9675-82. doi: 10.1074/jbc.271.16.9675.
3
Transport of amphipathic anions by human multidrug resistance protein 3.人多药耐药蛋白3对两亲性阴离子的转运
Cancer Res. 2000 Sep 1;60(17):4779-84.
4
ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.多药耐药蛋白MRP1介导的化疗药物的ATP和谷胱甘肽依赖性转运
Br J Pharmacol. 1999 Feb;126(3):681-8. doi: 10.1038/sj.bjp.0702360.
5
Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.通过与膳食类黄酮相互作用调节多药耐药蛋白1(MRP1/ABCC1)的转运和ATP酶活性。
Mol Pharmacol. 2001 May;59(5):1171-80. doi: 10.1124/mol.59.5.1171.
6
Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).人类多药耐药蛋白7(MRP7,ABCC10)转运特性的表征
Mol Pharmacol. 2003 Feb;63(2):351-8. doi: 10.1124/mol.63.2.351.
7
Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles.利用纯化的多药耐药蛋白MRP1(ABCC1)在磷脂囊泡中对底物转运进行功能重建。
J Biol Chem. 2000 Nov 3;275(44):34166-72. doi: 10.1074/jbc.M004584200.
8
Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1).维拉帕米可刺激190 kDa多药耐药蛋白1(MRP1)介导的谷胱甘肽转运。
J Pharmacol Exp Ther. 2000 May;293(2):530-8.
9
ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids.多药耐药蛋白(MRP)介导的ATP依赖性17β-雌二醇17-(β-D-葡萄糖醛酸苷)转运。胆汁淤积性类固醇的抑制作用。
J Biol Chem. 1996 Apr 19;271(16):9683-9. doi: 10.1074/jbc.271.16.9683.
10
Flow cytometric monitoring of multidrug drug resistance protein 1 (MRP1/ABCC1) -mediated transport of 2',7'-bis-(3-carboxypropyl)-5-(and-6)- carboxyfluorescein (BCPCF) into human erythrocyte membrane inside-out vesicles.流式细胞术监测多药耐药蛋白1(MRP1/ABCC1)介导的2',7'-双(3-羧丙基)-5-(和-6)-羧基荧光素(BCPCF)转运至人红细胞膜外翻小泡内的过程。
Mol Membr Biol. 2007 Sep-Dec;24(5-6):485-95. doi: 10.1080/09687680701383069.

引用本文的文献

1
Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System.预测药物性胆汁淤积的当前模型:肝胆转运系统的作用。
Iran J Pharm Res. 2021 Spring;20(2):1-21. doi: 10.22037/ijpr.2020.113362.14254.
2
Inhibition of the MRP1-mediated transport of the menadione-glutathione conjugate (thiodione) in HeLa cells as studied by SECM.通过 SECM 研究 MRP1 介导的 menadione-glutathione 共轭物(硫代二酮)在 HeLa 细胞中的转运抑制作用。
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11522-7. doi: 10.1073/pnas.1201555109. Epub 2012 Jun 7.
3
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.
一种基于分子的伊立替康昼夜递药优化的联合实验和数学方法。
PLoS Comput Biol. 2011 Sep;7(9):e1002143. doi: 10.1371/journal.pcbi.1002143. Epub 2011 Sep 8.
4
Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.多药耐药相关蛋白2相互作用的构效关系研究进展。
AAPS J. 2009 Sep;11(3):406-13. doi: 10.1208/s12248-009-9117-0. Epub 2009 Jun 3.